Thrombocytopenic purpura

Search with Google Search with Bing
Information
Disease name
Thrombocytopenic purpura
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00117143 Completed Phase 1/Phase 2 Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) December 2, 2002 July 19, 2004
NCT00415532 Completed Phase 3 Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura December 1, 2006 May 11, 2009
NCT00454857 Completed Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) May 2006 August 2008
NCT00508820 Completed Phase 3 An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP February 1, 2005 March 1, 2011
NCT01444417 Completed Phase 3 Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients January 2012 February 2015
NCT03244410 Unknown status Lymphocyte Counts in Immune Thrombocytopenic Purpura October 2017 January 2019